Skip to main content
Search
Search
Czech Republic
|
en
Choose Location
Czech Republic
|
Czech
English
Americas
Asia Pacific
Europe
International
Middle East & Africa
Argentina |
es
Brazil |
pt
Canada |
en
Canada |
fr
Central America |
es
Colombia |
es
Mexico |
es
United States |
en
Venezuela |
es
Australia |
en
Bangladesh |
en
Hong Kong S.A.R. |
zh
India |
en
Indonesia |
en
Japan |
ja
Korea |
ko
Mainland China |
zh
Malaysia |
en
Pakistan |
en
Philippines |
en
Singapore |
en
Taiwan |
zh
Austria |
de
Belgium |
fr
Belgium |
nl
Bulgaria |
bg
Czech Republic |
cs
Czech Republic |
en
Denmark |
da
Estonia |
et
Finland |
fi
France |
fr
Germany |
de
Greece |
el
Hungary |
hu
Ireland |
en
Italy |
it
Latvia |
lv
Lithuania |
lt
Netherlands |
nl
Norway |
no
Poland |
pl
Portugal |
pt
Romania |
ro
Russia |
ru
Serbia |
sr
Slovakia |
sk
Spain |
es
Sweden |
sv
Switzerland |
de
Switzerland |
fr
United Kingdom |
en
Global |
en
Novartis Foundation |
en
Sandoz |
en
Egypt |
en
Israel |
he
South Africa |
en
Turkey |
tr
Czech Republic
Choose Location
Czech Republic
Czech
English
europe
Americas
Asia Pacific
Europe
International
Middle East & Africa
Argentina |
es
Australia |
en
Austria |
de
Bangladesh |
en
Belgium |
fr
Belgium |
nl
Brazil |
pt
Bulgaria |
bg
Canada |
en
Canada |
fr
Central America |
es
Colombia |
es
Czech Republic |
cs
Czech Republic |
en
Denmark |
da
Egypt |
en
Estonia |
et
Finland |
fi
France |
fr
Germany |
de
Global |
en
Greece |
el
Hong Kong S.A.R. |
zh
Hungary |
hu
India |
en
Indonesia |
en
Ireland |
en
Israel |
he
Italy |
it
Japan |
ja
Korea |
ko
Latvia |
lv
Lithuania |
lt
Mainland China |
zh
Malaysia |
en
Mexico |
es
Netherlands |
nl
Norway |
no
Novartis Foundation |
en
Pakistan |
en
Philippines |
en
Poland |
pl
Portugal |
pt
Romania |
ro
Russia |
ru
Sandoz |
en
Serbia |
sr
Singapore |
en
Slovakia |
sk
South Africa |
en
Spain |
es
Sweden |
sv
Switzerland |
de
Switzerland |
fr
Taiwan |
zh
Turkey |
tr
United Kingdom |
en
United States |
en
Venezuela |
es
Menu
About
Novartis in the Czech Republic
Strategy
Diversity and inclusion
People and culture
Products
Country leadership team
Our mission and vision
Innovative medicines
Contact
About
Patients and caregivers
Novartis commitment to patients and caregivers
Our patient portals for Czech Republic
Products
Adverse event reporting
Provision of gifts and grants
Patients and Caregivers
Healthcare professionals
Healthcare professional country resource
Products
Novartis pipeline
Adverse event reporting
Novartis clinical trials
Clinical trials in Czech Republic
VPOIS
Expert information
Healthcare Professionals
Research and development
Research and development in Czech Republic
Research and development
ESG
Ethics, risk and compliance
Access
Environmental sustainability
Global health
Ethical behavior
Whistleblow line
ESG
News
News archive
Stories
Media library
Media contacts
News
Careers
Career search
Meet the teams
Personal growth
Early talent
How we work
Leadership trainee program
Well-being
Diversity and inclusion
Awards and recognition
Careers
Coronavirus
Coronavirus
Home
Home
About
Contact
Office Info Czech Republic
Office Info Czech Republic
Novartis s.r.o.
Na Pankráci 1724/129
140 00, Praha 4
Česká republika
Related links
Novartis in the Czech Republic
Research and development in Czech Republic
Clinical Trials in Czech Republic
Our patient portals for Czech Republic
AddToAny buttons
Printable Links Block (Content)
Print
PDF
